R&D Systems Inc. Tocris Bioscience Boston Biochem

Other Cannabinoids

Inhibitors
Cat.No.
Product Name / Activity
1462 AACOCF3
FAAH inhibitor
3381 AM 1172
FAAH inhibitor. Also anandamide uptake inhibitor and CB receptor partial agonist
3262 JNJ 1661010
Selective, reversible FAAH inhibitor
2452 LY 2183240
FAAH inhibitor. Also inhibits anandamide uptake
1421 MAFP
Potent, irreversible FAAH inhibitor
1815 Palmitoylisopropylamide
Inhibitor of FAAH
4175 PF 3845
Selective FAAH inhibitor
3307 PF 750
Selective FAAH inhibitor
4752 SA 57
Potent FAAH inhibitor
4355 TC-F 2
Potent, reversible and selective FAAH inhibitor
3252 WWL 70
Potent ABHD6 inhibitor
Other
Cat.No.
Product Name / Activity
2836 Arachidonyl serotonin
Dual FAAH inhibitor/TRPV1 antagonist
1814 N-ArachidonylGABA
Inhibits pain in vivo
1445 N-Arachidonylglycine
Novel endocannabinoid. Suppresses pain in vivo
2288 O-1918
Silent antagonist for putative abnormal-CBD (Cat. No. 1297) receptor
0879 Palmitoylethanolamide
FAAH and PAA substrate. Selective GPR55 agonist
2206 2-Palmitoylglycerol
Endogenous lipid; enhances activity of 2-arachidonylglycerol (Cat. No. 1298)
1684 Tocrisolve™ 100
Water-soluble emulsion; negative control for reagents in TocrisolveTM 100

Quick Order

Find multiple products by catalog number

divider line

Pain Research Product Guide

Pain Research Guide

Highlights over 280 products for Pain research. Request copy or view PDF today.

divider line

Cannabinoid Review

Cannabinoid Receptor Ligands Review

Written by Roger Pertwee, an expert. Request a copy or view PDF today.

divider line

7-TM Receptor Signaling

Written by T. Kenakin et al

7-TM Poster

'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

20% Discount*

Potent, selective LRRK2 inhibitor

Potent LRRK2 inhibitor now available from Tocris Bioscience

Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

* Terms & conditions